Sutro Biopharma, Inc. (STRO) SEC Filings — 2024
25 SEC filings for Sutro Biopharma, Inc. (STRO) in 2024.
Filings
- Sutro Biopharma Files 8-K — 8-K · Dec 10, 2024
- Sutro Biopharma, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Sutro Biopharma, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Sutro Biopharma, Inc. SC 13G/A Filing — SC 13G/A · Nov 13, 2024
- Sutro Biopharma Files Q3 2024 10-Q — 10-Q · Nov 13, 2024
- Sutro Biopharma, Inc. SC 13G/A Filing — SC 13G/A · Nov 12, 2024
- Sutro Biopharma, Inc. SC 13G/A Filing — SC 13G/A · Nov 12, 2024
- Sutro Biopharma, Inc. SC 13G/A Filing — SC 13G/A · Nov 4, 2024
- Sutro Biopharma, Inc. SC 13G/A Filing — SC 13G/A · Nov 4, 2024
- Sutro Biopharma R&D Surges in Q2 2024 — 10-Q · Aug 13, 2024
- Sutro Biopharma Appoints New CMO, Adds Director — 8-K · Aug 12, 2024
- Sutro Biopharma Reports Shareholder Vote Matters — 8-K · Jun 10, 2024
- Sutro Biopharma Files Proxy Supplement — DEFA14A · May 17, 2024
- Sutro Biopharma, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 13, 2024
- Sutro Biopharma, Inc. Files DEF 14A with Executive Compensation Details — DEF 14A · Apr 26, 2024
- Sutro Biopharma, Inc. SC 13G Filing — SC 13G · Apr 5, 2024
- Sutro Biopharma Files 8-K: Material Agreement & Equity Sales — 8-K · Apr 2, 2024
- Sutro Biopharma, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 25, 2024
- Sutro Biopharma, Inc. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- Rubric Capital Discloses 5.0% Stake in Sutro Biopharma — SC 13G/A · Feb 12, 2024
- Sutro Biopharma Files 8-K for 'Other Events' & Exhibits — 8-K · Feb 9, 2024
- Adage Capital Partners Amends Sutro Biopharma Stake — SC 13G/A · Feb 7, 2024
- BlackRock Amends Sutro Biopharma Stake, Maintains Significant Position — SC 13G/A · Jan 24, 2024
- Millennium Affiliate Discloses New Passive Stake in Sutro Biopharma — SC 13G · Jan 17, 2024
- Sutro Biopharma Confirms Non-Emerging Growth Company Status — 8-K · Jan 8, 2024